/People

Roel Bulthuis

Investor

Managing Partner & Head of Investments at Syncona

Amsterdam, Netherlands

Writes $100K – $5M checks · typically $1.5M

Kauffman Fellow · Class 22

Find your path to Roel

Sign up to see every warm intro you have to Roel

  • Paths you didn't know you had: your email and LinkedIn already hold routes to Roel. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

About

Roel Bulthuis is a Managing Partner at Syncona, where he leads the investment team and draws on over 20 years of experience in life science venture capital, business development, and investment banking. He previously served as Managing Partner and head of healthcare at Inkef Capital, and before that as SVP and Managing Director of Merck Group's M-Ventures, following senior business development roles at Merck Serono and a position in investment banking at Fortis Bank. He holds an MSc in Biopharmaceutical Sciences from Leiden University and an MBA in Finance from the Helsinki School of Economics, and is a Kauffman fellow and Level20 mentor.

Invests in

Biotech

Deals · 2

QuralisBoard seat

via Syncona · filed Sep 2022 · $10M raise

Ambagon TherapeuticsBoard seat

via Syncona · filed Jun 2022 · $85M raise

Attribution from SEC filings, press coverage, and firm rosters.

Other disclosed investments

Board seats

AnaveoniOncturaRe-Aim TherapeuticsResolution Therapeutics

Investor

aveniBird Rock BioComet TherapeuticsF-Star TherapeuticsiOncturaNMD PharmaRe-Aim TherapeuticsSalvia BioelectronicsVarmX

Sources: SEC Form D filings · the firm's website · curated public sources.

Colleagues at Syncona

Frequently asked questions

Who is Roel Bulthuis?
Roel Bulthuis is a Managing Partner at Syncona, where he leads the investment team and draws on over 20 years of experience in life science venture capital, business development, and investment banking. He previously served as Managing Partner and head of healthcare at Inkef Capital, and before that as SVP and Managing Director of Merck Group's M-Ventures, following senior business development roles at Merck Serono and a position in investment banking at Fortis Bank. He holds an MSc in Biopharmaceutical Sciences from Leiden University and an MBA in Finance from the Helsinki School of Economics, and is a Kauffman fellow and Level20 mentor.
Where does Roel Bulthuis work?
Roel Bulthuis is Managing Partner & Head of Investments at Syncona.
What does Roel Bulthuis invest in?
Roel Bulthuis invests in Biotech.
What check size does Roel Bulthuis write?
Roel Bulthuis typically writes checks of $100K – $5M.
What boards does Roel Bulthuis sit on?
Roel Bulthuis holds tracked board seats at Ambagon Therapeutics, Anaveon, iOnctura, Quralis, Re-Aim Therapeutics, Resolution Therapeutics.
What companies has Roel Bulthuis invested in?
Investments tracked here include aveni, Bird Rock Bio, Comet Therapeutics, F-Star Therapeutics, iOnctura, NMD Pharma, Quralis, Re-Aim Therapeutics, Salvia Bioelectronics, VarmX.

About this profile. Compiled from public sources — Syncona's own website, regulatory filings and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights